Jul 172020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– ISRAEL, Kfar Saba – CartiHeal, developer of the proprietary Agili-C implant for the treatment of joint surface lesions in traumatic and osteoarthritic joints, has secured an additional $15 million equity investment from Bioventus, a global leader in orthobiologics. The investment follows the recently completed enrollment and outcome of interim ...

CartiHeal raises $15m equity funding from Bioventus

CartiHeal raises $15m equity funding from Bioventus

From:: CartiHeal raises $15m equity funding from Bioventus

Sorry, the comment form is closed at this time.